Clearly, molecular modeling involves a detailed analysis of the complementarity of ligand and receptor structure.
However, this sort of molecular modeling rarely can be applied because the detailed structure of the receptor is usually unknown. Although these relationships consider the chemical differences between the substituent groups of the series of ligands, the 3D geometric relationships between the substituent groups are not addressed explicitly.
Extrapolation of a given QSAR to proposed ligands dissimilar to those of the original series is not valid. Thus, QSARs may be useful in extending a series but will not be useful for discovering new leads.
Between the two extremes of complete knowledge and no knowledge of the receptor structure lies the investigator has acquired limited knowledge of the structure of the receptor.. CAMD and discovery can be accomplished by searching large databases of 3D molecular structures for compounds that satisfy the chemical and 3D geometric criteria that constitute the description of the pharmacophore.
Only within last few years the pharmaceutical industry has been in a position to explore the utility of 3D-searching; already the results have been most encouraging. In every case, the search not only has returned "hits" similar to known active compounds but also has returned hits that were entirely unexpected, new classes of compounds (new lead compounds).
Four essential elements to implement 3D-searching capabilities are discussed below: (1) many interesting 3D molecular structures, (2) a chemical database management system, (3) the 3D-searching software, and (4) rationally determined search criteria.
